跳至主要内容
临床试验/NCT04555798
NCT04555798已完成1 期

The Immunoadsorption Effect of Arterio-venous ECMO in Refractory Septic Shock With ARDS Following Severe Lung Contusion

Mohamed Gaber Allam1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
100
试验地点
1
主要终点
number of patients weaned from ventilators

研究概览

简要总结

To evaluate and compare the effect of immunoadsorption effect of A-V ECMO on course of sepsis weaning from inotropes, weaning from the ventilator, duration of ICU stays and effect on mortality rate in patients with septic shock and respiratory failure due to ARDS followed severe lung contusion.

详细描述

100 patients with respiratory failure without improvement after 10 days ventilation due to development of VAP with ARDS, had >2 SOFA score and >6 CPIS score included in two groups 50 patients in each. Only patients of group B put on A-V ECMO while patients of group A continue on traditional way of management. Improvement of ARDS &VAP, weaning from ventilation, duration of ICU stays, improvement of one/all parameters of both SOFA and CPIS scores, morbidity and mortality recorded and compared within 14 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Those who had an age between 18-65 years old
  • patients ventilated for more than 10 days
  • with conscious level more than 8/15 on Glasgow Coma Scale

排除标准

  • pediatric patients below 18 years of age

研究组 & 干预措施

Group A

Placebo Comparator

Group A continue on the same conventional way of management as mentioned above with conventional way of ventilation and broad spectrum antibiotics coverage

干预措施: Meropenem Injection (Drug)

Group B

Active Comparator

group B who connected to (A-VECMO).with venous access from femoral vien and arterial cannulation using the femoral artery

干预措施: Meropenem Injection (Drug)

Group B

Active Comparator

group B who connected to (A-VECMO).with venous access from femoral vien and arterial cannulation using the femoral artery

干预措施: A-V ECMO (Device)

结局指标

主要结局

number of patients weaned from ventilators

时间窗: 2 weeks

who showed improvement in CPIS score

number of patients disharged from ICU

时间窗: 2 weeks

who successfully weaned from the ventilator and complete 24 hours observation without symptoms

次要结局

未报告次要终点

研究者

发起方
Mohamed Gaber Allam
申办方类型
Network
责任方
Sponsor Investigator
主要研究者

Mohamed Gaber Allam

Consultant intensivist

King Abdul Aziz Specialist Hospital

研究点 (1)

Loading locations...

相似试验